[Prevention and therapy of arrhythmias due to myocardial infarct].
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D000404:Ajmaline / Q000494:pharmacology / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007545:Isoproterenol / Q000494:pharmacology / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000150:complications*; D010672:Phenytoin / Q000494:pharmacology / Q000627:therapeutic use; D011342:Procainamide / Q000494:pharmacology / Q000627:therapeutic use; D011802:Quinidine / Q000494:pharmacology / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000404:Ajmaline; D010672:Phenytoin; D011802:Quinidine; D011342:Procainamide; D007545:Isoproterenol
Prophylaxe und Therapie infarktbedingter Rhythmusstörungen.